Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Lay's Classic Potato Chips Recall Upgraded To 'Class I' By FDA Due To Milk Allergen

According to the FDA, "Class I" level recalls are used when there is "reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death."

International Business Times

This country approves Ozempic to reduce risk of kidney disease in diabetes patients

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD).

The Times of India

Caroline Kennedy Slams 'Predator' Cousin RFK Jr. Ahead of Confirmation Hearing: 'No Surprise He Keeps Birds of Prey as Pets'

Caroline Kennedy condemns cousin RFK Jr. as a "predator" before his Senate confirmation for HHS, citing his controversial vaccine views, ethical lapses, history of drug addiction, and exploitation of family tragedies.

Latin Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Lay's potato chips recall in two USA states; FDA assigns most severe risk warning

Lay's Classic Potato Chips have been recalled in Oregon and Washington after undeclared milk, a major allergen, was found in over 6,000 bags. While FDA implemented this recall last month on December 13, it was classified as 'highest risk level' on January 27.

The Times of India

Trump Rolls Back FDA Menthol Ban

Biden's FDA pushed a prohibition that disproportionately targeted marginalized communities. Trump's reversal may mark a shift toward smarter drug policy.

Reason

Citi Analysts Think This Robotic AI Stock Can Surge Another 25% From Here

This robotic AI stock is a “buy and hold” stock for the long term despite its lofty valuation.

Barchart

What Does the Future Hold for Eli Lilly?

Eli Lilly's two major GLP-1 drugs have dominated headlines, but a slate of new treatments in development—and some already available—suggest a bright future.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Why Australia has embraced psychedelics

Australia recently became the first country to legalize both MDMA and psilocybin-assisted psychiatric therapy

Salon

FDA's Approval of Nicotine Pouches as a Step in Tobacco Harm Reduction

The FDA has recently authorized the sale of Zyn nicotine pouches, marking a pivotal moment in tobacco harm reduction. As concerns about traditional smoking persist, nicotine pouches present a viable alternative for adult smokers. This approval underscores their potential public health benefits, despite challenges surrounding youth appeal.

inkl

Costco’s smoked salmon recall is now classified as possibly deadly

The smoked salmon was sold at Costco locations in Florida and recalled due to contamination with listeria

The Independent UK

E. coli O26 Outbreaks: Lessons Learned from Recent Incidents

Escherichia coli O26 (E. coli O26) is a pathogenic strain of E. coli that has been responsible for several outbreaks in recent years. These incidents have provided valuable insights into the sources of contamination, the importance of food safety ...

USA Today Sports Media Group

Robert F Kennedy Jr has promised to Make America Healthy Again. Is his plan woo-woo or common sense?

RFK Jr’s plans to shake up American healthcare read like a wacky wellness guru meets green fingered environmentalist. Claudia Cockerell on what his appointment as Health Secretary means for the US

Evening Standard

Trump Administration Withdraws Proposed Menthol Cigarette Ban

The Trump administration withdrew a proposed menthol ban, despite potential health and economic benefits. Learn more about the implications and ongoing dis...

Top News

Federal Health Agency Communications Frozen By Trump Administration

Trump administration's freeze on federal health agency communications raises concerns about transparency and public safety.

MarketBeat

MaxCyte: Building the Future of Cell and Gene Therapy Innovation

MaxCyte's proprietary Flow Electroporation technology enables companies like Vertex and CRISPR Therapeutics to get FDA approved for their gene-editing therapy.

The Independent UK

Face moisturizer recalled: FDA issues advisory on First Aid Beauty Ultra Repair Cream

The First Aid Beauty ‘Ultra Repair Intense Hydration’ cream is typically a well-loved product that has previously gone viral on TikTok but now, users feel as if they’re being left in the dark

Fortune

Ketamine-derived nasal spray for depression now FDA-approved as stand-alone treatment

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

The Independent UK

Trump administration freezes many health agency reports and posts

The Trump administration has put a freeze on many federal health agency communications with the public through at least the end of the month

1 … 69 70 71 72

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.